What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation

Peter Chiu, Mark J. Russo, Ryan R Davies, Linda J. Addonizio, Marc E. Richmond, Jonathan M. Chen

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Currently, pulmonary vascular resistance index (PVRI) >6 WU × m 2 (indexed units) is generally considered a contraindication to isolated orthotopic heart transplantation (OHT). However, this has been questioned in the literature. A retrospective review was performed on all patients <18 years old who underwent primary OHT for cardiomyopathy. Data were collected with regard to demographics, pre-operative hemodynamics, need for pre-operative mechanical circulatory support, vasodilator reactivity and 30-day mortality (30dM). A receiver operating characteristic (ROC) curve was used to establish an optimal threshold. Uni- and multivariate logistic regressions were performed to assess the influence of PVRI on 30dM. Complete data were available for 158 cardiomyopathy patients <18 years of age, who underwent primary OHT between June 1984 and November 2010. The ROC curve yielded a threshold of 9.290 indexed units. Four of 19 patients (21.1%) with PVRI >9 died in the first 30 days. In patients with PVRI <9, there was only 1 death among 139 patients (0.7%). Odds of mortality increased incrementally with PVRI as a continuous variable, with an odds ratio (OR) of 1.35 per indexed unit (95% confidence interval 1.12 to 1.63). PVRI was dichomotomized (PVRId) using the previously established threshold and revealed an increasing risk of mortality, OR 36.80 (95% confidence interval 3.86 to 350.90), with a PVRI of >9 indexed units. Using a PVRI >6 as a contraindication to isolated OHT may be too restrictive. Patients with PVRI ≤9 do not appear to be at increased risk of early mortality. In patients with PVRI >9, 30-day survival was 78.9% in this study. This represents a viable alternative to heartlung transplantation.

Original languageEnglish (US)
Pages (from-to)61-66
Number of pages6
JournalJournal of Heart and Lung Transplantation
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Heart Transplantation
Vascular Resistance
Pediatrics
Transplantation
Survival
Mortality

Keywords

  • high-risk heart transplantation
  • pediatric heart transplantation
  • pulmonary hypertension
  • pulmonary vascular resistance index
  • right ventricular failure

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation. / Chiu, Peter; Russo, Mark J.; Davies, Ryan R; Addonizio, Linda J.; Richmond, Marc E.; Chen, Jonathan M.

In: Journal of Heart and Lung Transplantation, Vol. 31, No. 1, 01.01.2012, p. 61-66.

Research output: Contribution to journalArticle

Chiu, Peter ; Russo, Mark J. ; Davies, Ryan R ; Addonizio, Linda J. ; Richmond, Marc E. ; Chen, Jonathan M. / What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation. In: Journal of Heart and Lung Transplantation. 2012 ; Vol. 31, No. 1. pp. 61-66.
@article{6789a1f7069e4eca82a1d761d576b8c8,
title = "What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation",
abstract = "Currently, pulmonary vascular resistance index (PVRI) >6 WU × m 2 (indexed units) is generally considered a contraindication to isolated orthotopic heart transplantation (OHT). However, this has been questioned in the literature. A retrospective review was performed on all patients <18 years old who underwent primary OHT for cardiomyopathy. Data were collected with regard to demographics, pre-operative hemodynamics, need for pre-operative mechanical circulatory support, vasodilator reactivity and 30-day mortality (30dM). A receiver operating characteristic (ROC) curve was used to establish an optimal threshold. Uni- and multivariate logistic regressions were performed to assess the influence of PVRI on 30dM. Complete data were available for 158 cardiomyopathy patients <18 years of age, who underwent primary OHT between June 1984 and November 2010. The ROC curve yielded a threshold of 9.290 indexed units. Four of 19 patients (21.1{\%}) with PVRI >9 died in the first 30 days. In patients with PVRI <9, there was only 1 death among 139 patients (0.7{\%}). Odds of mortality increased incrementally with PVRI as a continuous variable, with an odds ratio (OR) of 1.35 per indexed unit (95{\%} confidence interval 1.12 to 1.63). PVRI was dichomotomized (PVRId) using the previously established threshold and revealed an increasing risk of mortality, OR 36.80 (95{\%} confidence interval 3.86 to 350.90), with a PVRI of >9 indexed units. Using a PVRI >6 as a contraindication to isolated OHT may be too restrictive. Patients with PVRI ≤9 do not appear to be at increased risk of early mortality. In patients with PVRI >9, 30-day survival was 78.9{\%} in this study. This represents a viable alternative to heartlung transplantation.",
keywords = "high-risk heart transplantation, pediatric heart transplantation, pulmonary hypertension, pulmonary vascular resistance index, right ventricular failure",
author = "Peter Chiu and Russo, {Mark J.} and Davies, {Ryan R} and Addonizio, {Linda J.} and Richmond, {Marc E.} and Chen, {Jonathan M.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.healun.2011.08.021",
language = "English (US)",
volume = "31",
pages = "61--66",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation

AU - Chiu, Peter

AU - Russo, Mark J.

AU - Davies, Ryan R

AU - Addonizio, Linda J.

AU - Richmond, Marc E.

AU - Chen, Jonathan M.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Currently, pulmonary vascular resistance index (PVRI) >6 WU × m 2 (indexed units) is generally considered a contraindication to isolated orthotopic heart transplantation (OHT). However, this has been questioned in the literature. A retrospective review was performed on all patients <18 years old who underwent primary OHT for cardiomyopathy. Data were collected with regard to demographics, pre-operative hemodynamics, need for pre-operative mechanical circulatory support, vasodilator reactivity and 30-day mortality (30dM). A receiver operating characteristic (ROC) curve was used to establish an optimal threshold. Uni- and multivariate logistic regressions were performed to assess the influence of PVRI on 30dM. Complete data were available for 158 cardiomyopathy patients <18 years of age, who underwent primary OHT between June 1984 and November 2010. The ROC curve yielded a threshold of 9.290 indexed units. Four of 19 patients (21.1%) with PVRI >9 died in the first 30 days. In patients with PVRI <9, there was only 1 death among 139 patients (0.7%). Odds of mortality increased incrementally with PVRI as a continuous variable, with an odds ratio (OR) of 1.35 per indexed unit (95% confidence interval 1.12 to 1.63). PVRI was dichomotomized (PVRId) using the previously established threshold and revealed an increasing risk of mortality, OR 36.80 (95% confidence interval 3.86 to 350.90), with a PVRI of >9 indexed units. Using a PVRI >6 as a contraindication to isolated OHT may be too restrictive. Patients with PVRI ≤9 do not appear to be at increased risk of early mortality. In patients with PVRI >9, 30-day survival was 78.9% in this study. This represents a viable alternative to heartlung transplantation.

AB - Currently, pulmonary vascular resistance index (PVRI) >6 WU × m 2 (indexed units) is generally considered a contraindication to isolated orthotopic heart transplantation (OHT). However, this has been questioned in the literature. A retrospective review was performed on all patients <18 years old who underwent primary OHT for cardiomyopathy. Data were collected with regard to demographics, pre-operative hemodynamics, need for pre-operative mechanical circulatory support, vasodilator reactivity and 30-day mortality (30dM). A receiver operating characteristic (ROC) curve was used to establish an optimal threshold. Uni- and multivariate logistic regressions were performed to assess the influence of PVRI on 30dM. Complete data were available for 158 cardiomyopathy patients <18 years of age, who underwent primary OHT between June 1984 and November 2010. The ROC curve yielded a threshold of 9.290 indexed units. Four of 19 patients (21.1%) with PVRI >9 died in the first 30 days. In patients with PVRI <9, there was only 1 death among 139 patients (0.7%). Odds of mortality increased incrementally with PVRI as a continuous variable, with an odds ratio (OR) of 1.35 per indexed unit (95% confidence interval 1.12 to 1.63). PVRI was dichomotomized (PVRId) using the previously established threshold and revealed an increasing risk of mortality, OR 36.80 (95% confidence interval 3.86 to 350.90), with a PVRI of >9 indexed units. Using a PVRI >6 as a contraindication to isolated OHT may be too restrictive. Patients with PVRI ≤9 do not appear to be at increased risk of early mortality. In patients with PVRI >9, 30-day survival was 78.9% in this study. This represents a viable alternative to heartlung transplantation.

KW - high-risk heart transplantation

KW - pediatric heart transplantation

KW - pulmonary hypertension

KW - pulmonary vascular resistance index

KW - right ventricular failure

UR - http://www.scopus.com/inward/record.url?scp=83555166246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83555166246&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2011.08.021

DO - 10.1016/j.healun.2011.08.021

M3 - Article

C2 - 22019236

AN - SCOPUS:83555166246

VL - 31

SP - 61

EP - 66

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 1

ER -